Literature DB >> 10717609

Quality of life in survivors of colorectal carcinoma.

S D Ramsey1, M R Andersen, R Etzioni, C Moinpour, S Peacock, A Potosky, N Urban.   

Abstract

BACKGROUND: Colon carcinoma is a common malignancy that accounts for a substantial share of all cancer-related morbidity and mortality. However, little is known with regard to general and disease specific quality of life in survivors of colorectal carcinoma, particularly from community-based samples of cases across stage and survival times from diagnosis.
METHODS: Subjects with colorectal carcinoma were recruited from the National Cancer Institute's Surveillance, Epidemiology, and End Results cancer registry. Subjects completed two self-administered surveys: the Functional Assessment of Cancer Therapy Scales for Colorectal Cancer (FACT-C) and the Health Utilities Index (HUI) Mark III.
RESULTS: One hundred seventy-three respondents (average age: 70.4 years, 71.4% female) completed the survey. In the first 3 years after diagnosis, quality of life was lower and varied substantially among respondents. After 3 years, respondents in all TNM stages of disease except Stage IV reported a relatively uniform and high quality of life. Pain, functional well-being, and social well-being were affected most substantially across all stages and times from diagnosis. Low income status was associated with worse outcomes for pain, ambulation, and social and emotional well-being. Only emotional well-being scores improved significantly over time in both surveys.
CONCLUSIONS: Those individuals who achieve a long term remission from colorectal carcinoma may experience a relatively high quality of life, although deficits remain for several areas, particularly in those of low socioeconomic status. Sampling design may have excluded the most severely ill patients. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 10717609

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  95 in total

1.  Adjusting distributions of the Health Utilities Index Mark 3 utility scores of health-related quality of life.

Authors:  Jian Sun
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

2.  The association between chronic disease burden and quality of life among breast cancer survivors in Missouri.

Authors:  Anjali D Deshpande; Julianne A Sefko; Donna B Jeffe; Mario Schootman
Journal:  Breast Cancer Res Treat       Date:  2011-04-26       Impact factor: 4.872

3.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Authors:  Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; James E Savarino; Marjolein van Ballegooijen; Karen M Kuntz; Ann G Zauber
Journal:  J Natl Cancer Inst       Date:  2010-07-27       Impact factor: 13.506

4.  Candidate Predictors of Health-Related Quality of Life of Colorectal Cancer Survivors: A Systematic Review.

Authors:  Martijn J L Bours; Bernadette W A van der Linden; Renate M Winkels; Fränzel J van Duijnhoven; Floortje Mols; Eline H van Roekel; Ellen Kampman; Sandra Beijer; Matty P Weijenberg
Journal:  Oncologist       Date:  2016-02-24

5.  Anxiety, depression and quality of life in colorectal cancer patients.

Authors:  Akira Tsunoda; Kentaro Nakao; Kenshi Hiratsuka; Naokuni Yasuda; Miki Shibusawa; Mitsuo Kusano
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.402

6.  Real-world cost-effectiveness of oxaliplatin in stage III colon cancer: a synthesis of clinical trial and daily practice evidence.

Authors:  Chantal W M van Gils; Saskia de Groot; William K Redekop; Miriam Koopman; Cornelis J A Punt; Carin A Uyl-de Groot
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

7.  Patient quality of life and short-term surgical outcomes between robotic and laparoscopic anterior resection for adenocarcinoma of the rectum.

Authors:  D Kamali; K Omar; S Z Imam; A Jha; A Reddy; M Jha
Journal:  Tech Coloproctol       Date:  2017-05-30       Impact factor: 3.781

8.  Preference values associated with stage III colon cancer and adjuvant chemotherapy.

Authors:  Jennie H Best; Louis P Garrison; William Hollingworth; Scott D Ramsey; David L Veenstra
Journal:  Qual Life Res       Date:  2010-04       Impact factor: 4.147

9.  Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.

Authors:  Uri Ladabaum; Ajitha Mannalithara; Joel V Brill; Zachary Levin; Kate M Bundorf
Journal:  Am J Gastroenterol       Date:  2018-06-15       Impact factor: 10.864

10.  Prospective evaluation of health-related quality of life after laparoscopic colectomy for cancer.

Authors:  G E Theodoropoulos; T Karantanos; P Stamopoulos; G Zografos
Journal:  Tech Coloproctol       Date:  2012-10-13       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.